AU4318901A - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
AU4318901A
AU4318901A AU4318901A AU4318901A AU4318901A AU 4318901 A AU4318901 A AU 4318901A AU 4318901 A AU4318901 A AU 4318901A AU 4318901 A AU4318901 A AU 4318901A AU 4318901 A AU4318901 A AU 4318901A
Authority
AU
Australia
Prior art keywords
membrane
nail
forming
solvent
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU4318901A
Other languages
English (en)
Inventor
Robert J Gyurik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bentley Pharmaceuticals Inc
Original Assignee
Bentley Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bentley Pharmaceuticals Inc filed Critical Bentley Pharmaceuticals Inc
Publication of AU4318901A publication Critical patent/AU4318901A/xx
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU4318901A 2000-02-16 2001-02-16 Pharmaceutical composition Pending AU4318901A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18292400P 2000-02-16 2000-02-16
PCT/US2001/005302 WO2001060325A1 (en) 2000-02-16 2001-02-16 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
AU4318901A true AU4318901A (en) 2001-08-27

Family

ID=22670647

Family Applications (2)

Application Number Title Priority Date Filing Date
AU4318901A Pending AU4318901A (en) 2000-02-16 2001-02-16 Pharmaceutical composition
AU2001243189A Ceased AU2001243189B2 (en) 2000-02-16 2001-02-16 Pharmaceutical composition

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2001243189A Ceased AU2001243189B2 (en) 2000-02-16 2001-02-16 Pharmaceutical composition

Country Status (17)

Country Link
EP (1) EP1257248B1 (enExample)
JP (1) JP2005503318A (enExample)
KR (2) KR20030016227A (enExample)
CN (1) CN1422142A (enExample)
AT (1) ATE526917T1 (enExample)
AU (2) AU4318901A (enExample)
BR (1) BR0108438A (enExample)
CA (1) CA2400178A1 (enExample)
HU (1) HUP0204555A3 (enExample)
MA (1) MA26883A1 (enExample)
MX (1) MXPA02008072A (enExample)
NO (1) NO20023866L (enExample)
NZ (1) NZ520749A (enExample)
PL (1) PL357111A1 (enExample)
TW (1) TWI232756B (enExample)
WO (1) WO2001060325A1 (enExample)
ZA (1) ZA200206553B (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6585963B1 (en) * 2001-02-15 2003-07-01 Watson Pharmaceuticals, Inc. Nail compositions and methods of administering same
GB0203276D0 (en) * 2002-02-12 2002-03-27 Novartis Ag Organic compounds
PT1545619E (pt) 2002-09-05 2008-02-28 Galderma Sa Solução destinada a uma aplicação sobre as unhas
HRP20050918A2 (en) * 2003-03-21 2006-12-31 Nexmed Holdings Antifungal nail coat and method of use
US8741332B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for dermally treating neuropathic pain
US8741333B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
US8907153B2 (en) 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
JP5010125B2 (ja) * 2005-09-02 2012-08-29 有限会社日本健康科学研究センター 水虫治療用フィルム製剤
EP1947938A4 (en) * 2005-11-02 2009-07-01 Cpex Pharmaceuticals Inc MACROCYCLIC FORMULATIONS FOR TRANSMEMBRANAL DRUG DISPERSION
EP1959929A4 (en) * 2005-12-14 2012-08-15 Zars Pharma Inc COMPOSITIONS AND METHODS FOR TREATING DERMATOLOGICAL SUFFERING
WO2007077806A1 (ja) * 2005-12-28 2007-07-12 Teikoku Seiyaku Co., Ltd. 爪用医薬組成物
WO2008091588A1 (en) 2007-01-22 2008-07-31 Targacept, Inc. Intranasal, buccal, and sublingual administration of metanicotine analogs
JP5654497B2 (ja) * 2009-02-13 2015-01-14 トピカ ファーマシューティカルズ，インコーポレイテッド 抗真菌製剤
PL2408299T3 (pl) * 2009-03-20 2014-03-31 Stiefel Laboratories Kompozycje monoglicerydu kwasu tłuszczowego
GB201021386D0 (en) * 2010-12-16 2011-01-26 Burke Michael H A process for the manufacture of an antifungal nail lacquer
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
RS62297B1 (sr) 2011-11-23 2021-09-30 Therapeuticsmd Inc Prirodne kombinovane hormonske supstitucione formulacije i terapije
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
KR101580077B1 (ko) 2015-03-28 2015-12-24 한국콜마주식회사 시크로피록스 함유 네일락카 조성물
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US9931349B2 (en) 2016-04-01 2018-04-03 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
WO2026046372A1 (en) * 2024-08-30 2026-03-05 Shenzhen Pharmacin Co., Ltd. Compositions for nail conditions and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4299826A (en) * 1979-10-12 1981-11-10 The Procter & Gamble Company Anti-acne composition
US5731303A (en) * 1985-12-04 1998-03-24 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery compositions
US5023252A (en) * 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
DE3720147A1 (de) * 1987-06-16 1988-12-29 Hoechst Ag Antimykotisch wirksamer nagellack sowie verfahren zu dessen herstellung
EP0503312B1 (fr) * 1991-03-13 1997-01-08 Firmenich Sa Procédé de préparation de la 15-pentadécanolide ou de mélanges riches en cette macrolide
CA2211004A1 (en) * 1994-10-20 1996-05-02 The Procter & Gamble Company Personal treatment compositions and/or cosmetic compositions containing enduring perfume
US5693828A (en) * 1996-05-09 1997-12-02 International Flavors & Fragrances Inc. Process for preparing lactones and intermediates therefor
BR9904780A (pt) * 1998-02-09 2000-03-08 Macrochem Corp Esmalte fungicida para unhas e método de uso do mesmo
US6231875B1 (en) * 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
US6495124B1 (en) * 2000-02-14 2002-12-17 Macrochem Corporation Antifungal nail lacquer and method using same

Also Published As

Publication number Publication date
ATE526917T1 (de) 2011-10-15
JP2005503318A (ja) 2005-02-03
WO2001060325A1 (en) 2001-08-23
AU2001243189B2 (en) 2005-06-09
ZA200206553B (en) 2003-11-17
NZ520749A (en) 2004-06-25
CN1422142A (zh) 2003-06-04
BR0108438A (pt) 2003-04-01
CA2400178A1 (en) 2001-08-23
NO20023866D0 (no) 2002-08-15
MXPA02008072A (es) 2004-04-05
KR20030016227A (ko) 2003-02-26
HUP0204555A2 (en) 2003-05-28
TWI232756B (en) 2005-05-21
HUP0204555A3 (en) 2004-06-28
MA26883A1 (fr) 2004-12-20
EP1257248A1 (en) 2002-11-20
KR20080049148A (ko) 2008-06-03
EP1257248B1 (en) 2011-10-05
PL357111A1 (en) 2004-07-12
EP1257248A4 (en) 2007-10-03
NO20023866L (no) 2002-10-01

Similar Documents

Publication Publication Date Title
PL357111A1 (en) Pharmaceutical composition
UA27143C2 (uk) Рідка фармацевтичhа композиція в формі аерозолю
EA200000964A1 (ru) Жидкие полимерные композиции для регулируемого выделения биоактивных веществ
PT1150661E (pt) Produto para pulverizacao para aplicacao topica
CA2548897A1 (en) Endoparasiticidal agents for topical application
JP2005503318A5 (enExample)
WO2002080941A1 (en) Compositions for preparing external carbon dioxide agents
IS8870A (is) Lyfjablanda sem felur í sér andrógen
NZ504653A (en) Cosmetic compositions with dibenzylidene sorbitol and functionalized silicones
MY101536A (en) Anti-inflammatory and analgesic tape for external use
GEP20012462B (en) Composition for Aerosol Inhaler, Aerosol Inhaler and Method for Filling with the Composition
GEP20033129B (en) Pressurised Metered Dose Inhalers and Aerosol Formulation
EA200500084A1 (ru) Фармацевтическая композиция для чрескожной доставки активного агента
DE60029099D1 (de) Gerät und verfahren zur aerosolisierung einer pharmazeutischen pulverzusammensetzung
MXPA03005375A (es) Formulacion repelente de insectos que contiene solventes polares, que tiene baja viscosidad y de entrega mediante dispositivo piezoelectrico.
NO982006L (no) Terapeutisk preparat for transdermal tilf°rsel av virksomme stoffer gjennom huden
DE3783039D1 (de) Membran lipid zusammensetzung und verfahren zur herstellung.
EP1125497A3 (de) Mittel zur viruziden Händedesinfektion
ES2111272T3 (es) Mezclas herbicidas.
BR112021023276A2 (pt) Cartucho compreendendo nicotina e um solvente imiscível em água
JPH02290810A (ja) エアゾール製剤
CA2591307A1 (en) Injectable veterinary composition
AU2003229269A1 (en) Deposition method for endoprostheses provided for constantly administering medicaments
KR940006594A (ko) 후박 추출성분을 포함하는 치주질환 예방 치료제 조성물
ATE14437T1 (de) Aminoglycosid-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zusammensetzungen und solche derivate zur verwendung als arzneimittel.